The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP2 Portfolio I
Overview of the EDCTP2 portfolio of Collaborative Research & Development projects 2014-2019. profiles for each project.
EDCTP2 Portfolio II
Overview of the EDCTP2 Portfolio: Fellowship programme 2014-2019. Profiles for each fellowship.
World NTD Day: the fight to end Neglected Tropical Diseases
EDCTP is a proud partner and supporter of this first World NTD Day, a call to action to end the burden of the neglected tropical diseases (NTDs). Pivotal in the renewed global focus on NTDs was the London Declaration of…
PanACEA 2: New TB drug tested in patients for the first time in South Africa
The new promising tuberculosis drug BTZ-043 has been administered to patients for the first time in Cape Town, South Africa. This clinical study which is led by Professor Michael Hoeslcher of the Tropical Institute at the Hospital of the Ludwig-Maximilians…